Registered number
NI663097
eXRt Intelligent Healthcare Limited
Filleted Accounts
31 July 2025
eXRt Intelligent Healthcare Limited
Registered number: NI663097
Balance Sheet
as at 31 July 2025
Notes 2025 2024
£ £
Fixed assets
Tangible assets 4 12,371 14,283
Current assets
Debtors 5 74,522 25,507
Cash at bank and in hand 61,978 188,836
136,500 214,343
Creditors: amounts falling due within one year 6 (65,506) (56,422)
Net current assets 70,994 157,921
Total assets less current liabilities 83,365 172,204
Creditors: amounts falling due after more than one year 7 (194,319) (180,158)
Net liabilities (110,954) (7,954)
Capital and reserves
Called up share capital 268 268
Profit and loss account (111,222) (8,222)
Shareholders' funds (110,954) (7,954)
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr Dominic Holmes
Director
Approved by the board on 4 July 2026
eXRt Intelligent Healthcare Limited
Notes to the Accounts
for the year ended 31 July 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Fixtures, fittings and equipment 20% reducing balance
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
2 Government grants
Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attached to them and the grants will be received. Government grants are recognised using the accrual model and the performance model.
Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred, or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable.
Grants relating to assets are recognised in income on a systematic basis over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income and not deducted from the carrying amount of the asset.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
3 Employees 2025 2024
Number Number
Average number of persons employed by the company 4 4
4 Tangible fixed assets
Fixtures, fittings and equipment
£
Cost
At 1 August 2024 24,914
Additions 1,180
At 31 July 2025 26,094
Depreciation
At 1 August 2024 10,631
Charge for the year 3,092
At 31 July 2025 13,723
Net book value
At 31 July 2025 12,371
At 31 July 2024 14,283
5 Debtors 2025 2024
£ £
Taxation and social security costs 71,063 25,444
VAT 3,459 -
Other debtors - 63
74,522 25,507
6 Creditors: amounts falling due within one year 2025 2024
£ £
Convertible loan note 60,020 53,800
Taxation and social security costs 2,154 217
Other creditors 3,332 2,405
65,506 56,422
7 Creditors: amounts falling due after one year 2025 2024
£ £
Convertible loan note 194,319 180,158
The convertible loan note for £50,000 was issued to Ulster University. Interest will accrue at the Bank of England base rate plus 3% and shall be payable on the redemption or conversion date (as the case may be). Redemption of the loan, if relevant, will take place on the later of completion of the fund raising or on the 3rd anniversary of the instrument, which is 24 March 2025.
The convertible loan note for £180,000 was issued to Ulster University. Interest will accrue at the Bank of England base rate plus 3% and shall be payable on the redemption or conversion date (as the case may be). Redemption of the loan, if relevant, will take place on the later of completion of the fund raising or on the 3rd anniversary of the instrument, which is 15 July 2027.
8 Loans to directors
B/fwd Paid Repaid C/fwd
£ £ £ £
Dr Dominic Holmes (723) (312) (1,035)
(723) (312) - (1,035)
9 Other information
eXRt Intelligent Healthcare Limited is a private company limited by shares and incorporated in Northern Ireland. Its registered office is:
47b Glenshane Road
Knockloughrim
Magherafelt
BT45 8QR
eXRt Intelligent Healthcare Limited NI663097 false 2024-08-01 2025-07-31 2025-07-31 VT Final Accounts May 2026 Dr Dominic Holmes No description of principal activity NI663097 2023-08-01 2024-07-31 NI663097 core:WithinOneYear 2024-07-31 NI663097 core:AfterOneYear 2024-07-31 NI663097 core:ShareCapital 2024-07-31 NI663097 core:RetainedEarningsAccumulatedLosses 2024-07-31 NI663097 2024-08-01 2025-07-31 NI663097 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 NI663097 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 NI663097 bus:Director40 2024-08-01 2025-07-31 NI663097 1 2024-08-01 2025-07-31 NI663097 2 2024-08-01 2025-07-31 NI663097 core:PlantMachinery 2024-08-01 2025-07-31 NI663097 bus:Director3 2024-08-01 2025-07-31 NI663097 countries:England 2024-08-01 2025-07-31 NI663097 bus:FRS102 2024-08-01 2025-07-31 NI663097 bus:FilletedAccounts 2024-08-01 2025-07-31 NI663097 2025-07-31 NI663097 core:WithinOneYear 2025-07-31 NI663097 core:AfterOneYear 2025-07-31 NI663097 core:ShareCapital 2025-07-31 NI663097 core:RetainedEarningsAccumulatedLosses 2025-07-31 NI663097 core:PlantMachinery 2025-07-31 NI663097 2024-07-31 NI663097 core:PlantMachinery 2024-07-31 iso4217:GBP xbrli:pure